Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Colorectal Neoplasms 12Breast Neoplasms 12Pain 11Neoplasms 10Pain, Postoperative 9Prostatic Neoplasms 7Lung Neoplasms 6Agnosia 6Colonic Neoplasms 5Neuralgia 4Keratosis, Actinic 4Cancer Pain 4Liver Neoplasms 3Leiomyoma 3Head and Neck Neoplasms 3Chronic Pain 3Thyroid Neoplasms 2Stomach Neoplasms 2Pilonidal Sinus 2Oropharyngeal Neoplasms 2Neuroma 2Neoplasm Metastasis 2Myofibroma 2Inflammatory Bowel Diseases 2Ileus 2Diverticulitis 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urologic Neoplasms 1Urinary Bladder Neoplasms 1

Interventions

pembrolizumab 2fludarabine 2Radiosurgery 2Paclitaxel 2Gemcitabine 2Cyclophosphamide 2Cisplatin 2Carboplatin 2Anthropogenic Effects 2venetoclax 1umbralisib 1ublituximab 1regorafenib 1pazopanib 1niraparib 1neratinib 1lutetium Lu 177 dotatate 1ibrutinib 1grapiprant 1fludarabine phosphate 1famitinib 1encorafenib 1copanlisib 1cemiplimab 1capivasertib 1camrelizumab 1brigatinib 1binimetinib 1axicabtagene ciloleucel 1avelumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Disease Progression × Lidocaine × Clear all
NCT05560035 2022-09-29

The Effect of Intravenous Lidocaine on THBS2 and Angiogenic Factors Expression in Women Undergoing Cervical Cancer Surgery

General Hospital of Ningxia Medical University

Phase NA Unknown
60 enrolled
Gynecologic

Uterine Cervical Neoplasms, Neoplasm Metastasis, Disease Progression

Data powered by HemOnc (CC BY 4.0) Colophon âš¡